Cover Image

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats

Supinoxin is a novel anticancer drug candidate targeting the Y593 phospho-p68 RNA helicase, by exhibiting antiproliferative activity and/or suppression of tumor growth. This study aimed to characterize the in vitro and in vivo pharmacokinetics of supinoxin and attempt physiologically based pharmacok...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yoo-Kyung Song (Author), Yun-Hwan Seol (Author), Min Ju Kim (Author), Jong-Woo Jeong (Author), Hae-In Choi (Author), Seung-Won Lee (Author), Yoon-Jee Chae (Author), Sunjoo Ahn (Author), Young-Dae Gong (Author), Kyeong-Ryoon Lee (Author), Tae-Sung Koo (Author)
Format:	Book
Published:	MDPI AG, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
by: Yoo-Seong Jeong, et al.
Published: (2021)

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023)

Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells
by: Yoon-Jee Chae, et al.
Published: (2021)

Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats
by: Yoo-Kyung Song, et al.
Published: (2020)

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
by: Lien Thi Ngo, et al.
Published: (2022)

Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics
by: Myongjae Lee, et al.
Published: (2022)

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024)

Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations
by: Hyeon-Cheol Jeong, et al.
Published: (2022)

Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
by: Won-ho Kang, et al.
Published: (2021)

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Deok Yong Yoon, et al.
Published: (2021)

Prediction of gastric pH‐mediated drug exposure using physiologically‐based pharmacokinetic modeling: A case study of itraconazole
by: Eunsol Yang, et al.
Published: (2023)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
by: Min-Chang Kim, et al.
Published: (2022)

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021
by: Kyeong-Ryoon Lee, et al.
Published: (2022)

Evaluation for Potential Drug-Drug Interaction of MT921 Using In Vitro Studies and Physiologically-Based Pharmacokinetic Models
by: Hyo-jeong Ryu, et al.
Published: (2021)

Development of a Physiologically Based Pharmacokinetic Model for Tegoprazan: Application for the Prediction of Drug-Drug Interactions with CYP3A4 Perpetrators
by: Lien Thi Ngo, et al.
Published: (2023)

Physiologic and Pharmacokinetic Changes in Pregnancy
by: Maged eCostantine
Published: (2014)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015)

Population Pharmacokinetics of Primaquine in the Korean Population
by: Woo-Yul Lee, et al.
Published: (2021)

In vivo tissue pharmacokinetics of ERBB2‐specific binding oligonucleotide‐based drugs by PET imaging
by: Sun Mi Park, et al.
Published: (2023)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023)

Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans
by: Min-Soo Kim, et al.
Published: (2022)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics
by: Jaeok Lee, et al.
Published: (2019)

Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients
by: Hyun-moon Back, et al.
Published: (2019)

Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs
by: Sara Bettonte, et al.
Published: (2024)

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions
by: Stefan Willmann, et al.
Published: (2021)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
by: Lixia He, et al.
Published: (2022)

Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach
by: Anusha Balla, et al.
Published: (2021)

Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens
by: Kyo Won Lee, et al.
Published: (2019)

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study
by: Joo Young Na, et al.
Published: (2022)

Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis
by: Carlijn H. C. Litjens, et al.
Published: (2023)

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
by: Paul R. V. Malik, et al.
Published: (2019)

A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
by: Hannah M. Jones, et al.
Published: (2019)

The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling
by: Ghoneim AM, et al.
Published: (2020)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
by: Lukas Kovar, et al.
Published: (2020)

An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population
by: Khaled Abduljalil, et al.
Published: (2024)

Comparative Pharmacokinetics and Bioequivalence of Pour-On Ivermectin Formulations in Korean Hanwoo Cattle
by: Suyoung Kim, et al.
Published: (2023)

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
by: Jinliang Chen, et al.
Published: (2022)

Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and <i>O</i>-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically-Based Pharmacokinetic Modeling
by: Hyeon-Cheol Jeong, et al.
Published: (2019)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020)